Results

Total Results: 1,166 records

Showing results for "patient safety".

461. Insulin Delivery and Glucose Monitoring Methods: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar_research.pdf
     August 01, 2015 - Patient Stakeholder Baltimore, MD Ruth Horowitz, M.D. … Study design: Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention … Study design: Endpoint Classification: Safety Study Intervention Model: Single Group Assignment … Study design: Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention … Study design: Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention

462. Gout Executive-2016 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive-2016.pdf
     January 01, 2016 - The safety of tests used to diagnose gout also needs to be considered. … Potential safety concerns include acute physical discomfort from joint aspiration and long-term effects … Therefore, we have undertaken a systematic review of studies examining the accuracy and safety of tests … The focus of this report is on evaluating the validity and safety of existing diagnostic methods for … Summary of findings on comparative accuracy and safety of gout diagnostic methods Outcomes Level

463. Comparative Effectiveness of Adjunctive Devices to Remove Thrombi or Protect Against Distal Embolization in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention of Native Vessels (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_disposition-comments.pdf
     March 01, 2012 - Comparative Effectiveness of Adjunctive Devices to Remove Thrombi or Protect Against Distal Embolization in Patients … I think it is also important to note that safety is UNCLEAR given sparse data and lack of power. … Insufficient evidence compared between devices, and safety remains unclear. … Safety, because of potential type II error, is mostly unclear. … Due to type II error, the safety of these devices is unclear.

464. C-Diff-Infections-Surveillance-140925 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections-surveillance-140925.pdf
     January 01, 2014 - • There are no new significant safety concerns. … Patient characteristics Level of Evidence: Insufficient Insufficient patient information was … Notably, 21% of EIA-negative patients presented with severe CDI, including one patient who died of … Weiss et 2012 Safety analysis A total of 728 adults 116 healthy N/A; tolerability, In this safety analysis … , with a safety profile comparable with oral vancomycin.

465. Disposition of Comments for CER 160 Binge Eating Disorder (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/binge-eating-disposition-160504.pdf
     December 09, 2015 - Efficacy and Safety of Lisdexamfetamine for Treatment of Adults With Moderate to Severe Binge-Eating … the published data on which the drug was approved is inadequate to reach conclusions on long-term safety … However, these data should be presented, even if only to say that more data on longer terms safety … Efficacy and Safety of Lisdexamfetamine for Treatment of Adults With Moderate to Severe Binge-Eating … American College of Neuropsychopharmacology (ACNP 2012) • Lisdexamfetamine Dimesylate Safety and

466. Disposition of Comments Report for Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non-ST Elevation Myocardial Infarction (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_disposition-comments.pdf
     January 01, 2014 - Peer Reviewer 2 Methods The authors should consistently report separately efficacy and safety. … This section should be renamed “impact of clopidogrel loading on efficacy and safety of bivalirudin … Unfortunately, we do not have individual patient-level data available for analysis. … prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial. … PLATelet inhibition and patient Outcomes (PLATO) trial.

467. A Randomized Trial of Epidural Glucocorticoid Injections for Spinal Stenosis: A Brief Summary of Findings for Clinicians (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/glucocorticoid-injections_clinician.pdf
     June 01, 2016 - It often presents insidiously, with patients reporting lower extremity discomfort and paresthesias … Data from rigorous randomized controlled trials are limited regarding the effectiveness and safety of … glucocorticoids-plus- lidocaine group than in the lidocaine- alone group (0.29 vs. 0.17 events per patient … events with a transforaminal injection than with an interlaminar injec- tion (0.46 vs. 0.22 events per patient … POSSIBLE KEY POINTS FOR CLINICIAN AND PATIENT OR CAREGIVER DISCUSSIONS »» Lumbar spinal stenosis exhibits

468. Disposition of Comments Report for Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-pancreas_disposition-comments.pdf
     September 23, 2014 - Adoption of these standards benefits patient dose. … MITA’s approach builds upon existing manufacturer safety measures – including equipment safety standards … , protocol development, quality and safety checks, provider education programs and physician-developed … FNA saves 5% of patients from having un-needed Whipples 4. … AHRQ is a leading authority on research, reports, and other tools that examine the quality, safety,

469. Restless-Legs Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
     November 01, 2012 - Key Questions not only addressed short-term efficacy and safety but also assessed longer term benefits … • Report outcomes such as proportions of patients with remission of symptoms (IRLS score=0), patient … Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, … Efficacy and safety of pramipexole in restless legs syndrome. … A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome

470. Disposition of Comments Report for Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_disposition-comments.pdf
     June 12, 2012 - The safety during stress echo was shown with both genders (Males/females in contrast cohort = 57.4% … cohort study of 26,774 patients. … cohort study of 26,774 patients. … Another key objective identified was the safety of each modality. … the actual patient population of interest.

471. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children_executive.pdf
     February 01, 2012 - • Patient insight into illness. … Tables with the summary of findings for efficacy and safety are presented below. … A total of 36 studies compared outcomes across various patient subpopulations. … evidence: • Studies examining long-term (at least 6 months followup) efficacy and, particularly, the safety … Future high-quality research is needed in order to determine the relative effectiveness and safety among

472. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - prescription on the Internet by a company in Boise, ID (ABC Nutriceuticals, Inc.), although information on safety … of other medications for this indication, the ease of oxytocin administration, and its favorable safety … hypothalamus, and nucleus accumbens.5-8 Based on these findings, clinical trials are examining oxytocin’s safety … Internet from at least one company, ABC Nutriceuticals, Inc., Boise, ID, although information on safety … the potential for this intervention to disrupt health care delivery and patient management.

473. Nonopioid Pharmacologic Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonopioid-pharm-chronic-pain-protocol.pdf
     February 01, 2019 - shows only modest short-term benefits.6-10 Lack of evidence on long-term effectiveness8 and serious safety … Rationale for Evidence Review and What this Review Adds Requirements in the 2010 Patient Protection … Given this context, the complexity of treating chronic pain, and concerns regarding the safety and long-term … How do harms vary depending on: (1) the specific type or cause of pain, (2) patient demographics, (3 … Pharmacoepidemiology and drug safety. 2009;18(12):1166-75. 15. Higgins J, Green S.

474. Diagnosis of Celiac Disease: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/celiac-disease_clinician.pdf
     July 01, 2016 - Most patients with active celiac disease and many others with dermatitis herpetiformis have anti-EmA … The clinician should instruct the patient to stay on a gluten-containing diet before biopsy in most … endoscopy (VCE) for various suspected small-intestine pathologies, as no systematic reviews contained safety … systematic review represents a review of upper GI endoscopy in general, as no systematic reviews contained safety … Subpopulations �� Patients with gastrointestinal (GI) symptoms: EmA and tTG tests have very good to

475. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_june_2012.pdf
     January 01, 2012 - moderately high potential for impact on the health care system, provided additional efficacy and safety … announced the formal submission of a reply to the complete letter response issued by FDA over potential safety … concerns. 12 Along with updates to safety information about ongoing or completed studies, included … Experts expressed a desire for further data evaluating safety and efficacy of these modifications to … Efficacy and safety of exenatide once weekly versus liraglutide in subjects with type 2 diabetes

476. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_executive.pdf
     December 01, 2011 - In patients with ACS who are undergoing PCI of native vessels, which patient characteristics (e.g., gender … morbidity, mortality, safety, or health-related quality-of-life outcome. … For KQ 3, patient demographics (age, sex, and ethnicity); baseline patient health status (smoking history … In patients with ACS who are undergoing PCI of native vessels, which patient characteristics (e.g., gender … Individual patient-data meta-analysis comparing clinical outcome in patients with ST-elevation myocardial

477. Disposition of Comments Report for Comparative Effectiveness of Bariatric Surgery and Nonsurgical Therapy in Adults With Metabolic Conditions and a Body Mass Index of 30.0 to 34.9 kg/m2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-loss-surgery_disposition-comments.pdf
     June 05, 2013 - Conclusion The Conclusion Should More Robustly Acknowledge the Safety and Effectiveness of Non-Surgical … the conducting of a clinical trial that can produce strong evidence to support the effectiveness and safety … papers that have similar profiles, for example Vertruyen et al (page 143, line 3) and Carelli et al (Safety … level of evidence indicating effectiveness and safety and that long-term studies of bariatric surgery … in this patient population are needed to assess the overall safety and effectiveness compared to non-surgical

478. Introduction (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine-1_research.pdf
     February 01, 2009 - about the outcomes, clinical effectiveness, safety, and appropriateness of health care items and services … Most patients were female (78%) and white (74%). … DMARD use in all patients with RA. … Although our selection criteria likely reduced patient misclassification, any residual misclassification … Information on the effectiveness and safety of DMARDs and concurrent medications must inform individual

479. Renal-Artery-Stenosis Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_surveillance.pdf
     June 01, 2012 - the majority of conclusions for KQ1-KQ2 were not still valid • No FDA, Health Canada, and MHRA safety … magnitude/direction of changes in estimates, potential changes in practice or therapy preference, safety … Findings 63% treatment, a statin, and aspirin only); dose:NR; (n=76) clearance; Secondary: safety … NR; (n=76) Two years Primary: 20% or greater decrease in creatinine clearance; Secondary: safety … antihypertensive treatment, a statin, and aspirin only); dose:NR; (n=76) creatinine clearance; Secondary: safety

480. Microsoft Word - 3-DKE274__ACEI-ARB-DRI__Comments_Disposition_Table-21_Jan_2011 cyk _2_.docx (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
     October 07, 2011 - daily, which is achieved by doubling the dose at approximately 2-week intervals, as tolerated by the patient … For Results Key Question 2, safety information, please note that ACE inhibitors pose unique, albeit … congestive heart failure, or nephropathy); however all have examined an overlapping set of efficacy and safety … of “class effects”, specifically related to ACEIs and ARBs, discussing that mechanism of action, safety … We underscore the importance of updating any corollary materials (e.g., patient guides) in order to